- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Antioxidative and Cardioprotective Effects of Phyllanthus urinaria L. on Doxorubicin-Induced Cardiotoxicity
-
- Chularojmontri Linda
- Interdepartment of Pharmacology, Graduate School, Chulalongkorn University
-
- Wattanapitayakul Suvara Kimnite
- Department of Pharmacology, Faculty of Medicine, Srinakharinwirot University
-
- Herunsalee Angkana
- Medicinal Plant Research Institute, Department of Medical Science, Ministry of Public Health, Thailand
-
- Charuchongkolwongse Suphan
- Medicinal Plant Research Institute, Department of Medical Science, Ministry of Public Health, Thailand
-
- Niumsakul Somchit
- Medicinal Plant Research Institute, Department of Medical Science, Ministry of Public Health, Thailand
-
- Srichairat Supatra
- Department of Pharmacology, Faculty of Veterinary Medicine, Chulalongkorn University
Search this article
Description
Cardiac toxicity is a major adverse effect caused by doxorubicin (DOX) therapy. Many recent studies have shown that DOX toxicity involves generation of reactive oxygen species (ROS). Although protection or alleviation of DOX toxicity can be achieved by administration of antioxidant vitamins such as ascorbic acid and vitamin E, their cardioprotective effect remains controversial. Thus alternative naturally occurring antioxidants may potentially be candidates for antioxidant therapy. In this study, we investigated the antioxidative and cytoprotective effects of Phyllanthus urinaria (PU) against DOX toxicity using H9c2 cardiac myoblasts. The total antioxidant capacity of PU (1 mg/ml) was 5306.75±461.62 FRAP value (μM). DOX IC50 values were used to evaluate the cytoprotective effects of PU ethanolic extract (1 or 10 μg/ml) in comparison with those of ascorbic acid (VIT C, 100 μM) and N-acetylcysteine (NAC, 100 μM). PU treatments (1 or 10 μg/ml) dose dependently caused rightward DOX IC50 shifts of 2.8- and 8.5-fold, respectively while treatments with VIT C and NAC increased DOX IC50 by 3.3- and 4.2-fold, respectively. Additionally, lipid peroxidation and caspase-3 activity were parameters used to evaluate cytoprotective effect. All antioxidants completely inhibited cellular lipid peroxidation and caspase-3 activation induced by DOX (1 μM). Endogenous antioxidant defense such as total glutathione (tGSH), catalase and superoxide dismutase (SOD) activity was also modulated by the antioxidants. PU treatment alone dose dependently increased tGSH, and this effect was retained in the presence of DOX. Similar effect was observed in the assessment of catalase and SOD enzyme activity. The nuclear factor κB (NFκB) transcription factor assay demonstrated that all antioxidants significantly inhibited DOX-induced NFκB activation. Our results suggest that PU protection against DOX cardiotoxicity was mediated through multiple pathways and this plant may serve as an alternative source of antioxidants for prevention of DOX cardiotoxicity.
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 28 (7), 1165-1171, 2005
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204627597440
-
- NII Article ID
- 10016664996
-
- NII Book ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 7343336
-
- PubMed
- 15997091
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed